Fennec Pharmaceuticals (FENC) Finished Goods (2022 - 2025)

Fennec Pharmaceuticals' Finished Goods history runs 4 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• Quarterly Finished Goods rose 47.64% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 47.64% YoY) and the FY2025 annual result came in at $1.6 million, up 47.64% from the prior year.
• Finished Goods was $1.6 million for Q4 2025 at Fennec Pharmaceuticals, down from $2.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $2.5 million in Q3 2025 and bottomed at $576000.0 in Q4 2022.
• A 4-year average of $1.6 million and a median of $1.6 million in 2025 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2023 — Finished Goods surged 274.31% — and 2024, when it sank 50.83%.
• Fennec Pharmaceuticals' Finished Goods stood at $576000.0 in 2022, then jumped by 274.31% to $2.2 million in 2023, then sank by 50.83% to $1.1 million in 2024, then jumped by 47.64% to $1.6 million in 2025.
• Business Quant data shows FENC's Finished Goods at $1.6 million in Q4 2025, $2.5 million in Q3 2025, and $2.2 million in Q2 2025.